Abstract Objective The role of Galectin-3 (Gal-3) in atherosclerosis progression has not been
definitely acknowledged. The aim of the study was to establish the following: whether Gal-3 …

Background The relationship between galectin-3 (Gal-3) and coronary artery disease (CAD)
has not been fully elucidated. Aim This study aimed to determine the relationship between …

Atherosclerosis is a complex process mediated by leukocytes, macrophages and various
inflammatory markers. Galectin-3 is secreted by activated macrophages and is involved in …

Objective—Galectin-3 (Gal-3) can affect atherogenesis by multiple mechanisms, but it
remains scarcely known whether plasma Gal-3 levels predict cardiovascular events in …

Objectives: Galectin-3 (Gal-3) is involved in cardiac inflammation and fibrosis, and is in use
as a biomarker that indicates increased risk in heart failure. This study examined the …

Abstract Background: Galectin-3 (Gal-3) is implicated in cardiac fibrosis, but its association
with adverse outcomes after myocardial infarction (MI) is unknown. Objectives: The purpose …

Background and aims Galectin-3 binding protein (Gal-3BP) is a secreted protein associated
with inflammation and carotid atherosclerosis. We hypothesized that high Gal-3BP levels …

Inflammation plays a key role in atherosclerosis. Galectin-3 is a macrophage-and
endothelium-derived mediator actively involved in the regulation of many aspects of …

Galectin-3 is a new biomarker that is assumed to reflect fibrogenesis and inflammation. In
this study, we aimed to evaluate the levels of galectin-3 in patients with acute coronary …

Aim: This study investigated the impact of the circulating galectin-3 level on the 30-day
prognostic outcome in patients with ST-segment elevation myocardial infarction (STEMI) …